{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:38:48Z","timestamp":1784191128016,"version":"3.55.0"},"reference-count":39,"publisher":"Cambridge University Press (CUP)","issue":"6","license":[{"start":{"date-parts":[[2014,7,31]],"date-time":"2014-07-31T00:00:00Z","timestamp":1406764800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["journals.cambridge.org"],"crossmark-restriction":true},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2015,4]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>This retrospective, descriptive case-series reviews the clinical presentations and significant laboratory findings of patients diagnosed with and treated for injectional anthrax (IA) since December 2009 at Monklands Hospital in Central Scotland and represents the largest series of IA cases to be described from a single location. Twenty-one patients who fulfilled National Anthrax Control Team standardized case definitions of confirmed, probable or possible IA are reported. All cases survived and none required limb amputation in contrast to an overall mortality of 28% being experienced for this condition in Scotland. We document the spectrum of presentations of soft tissue infection ranging from mild cases which were managed predominantly with oral antibiotics to severe cases with significant oedema, organ failure and coagulopathy. We describe the surgical management, intensive care management and antibiotic management including the first description of daptomycin being used to treat human anthrax. It is noted that some people who had injected heroin infected with<jats:italic>Bacillus anthracis<\/jats:italic>did not develop evidence of IA. Also highlighted are biochemical and haematological parameters which proved useful in identifying deteriorating patients who required greater levels of support and surgical debridement.<\/jats:p>","DOI":"10.1017\/s0950268814001885","type":"journal-article","created":{"date-parts":[[2014,7,31]],"date-time":"2014-07-31T13:42:23Z","timestamp":1406814143000},"page":"1311-1321","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":6,"title":["Injectional anthrax at a Scottish district general hospital"],"prefix":"10.1017","volume":"143","author":[{"given":"D. J.","family":"INVERARITY","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. M.","family":"FORRESTER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. G. R.","family":"CUMMING","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. J.","family":"PATERSON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J.","family":"CAMPBELL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. J. G.","family":"BROOKS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. L.","family":"CARSON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. P.","family":"RUDDY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2014,7,31]]},"reference":[{"key":"S0950268814001885_ref34","doi-asserted-by":"publisher","DOI":"10.1086\/657408"},{"key":"S0950268814001885_ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)74363-7"},{"key":"S0950268814001885_ref14","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.93B3.25976"},{"key":"S0950268814001885_ref26","unstructured":"Health Protection Scotland. Interim clinical guidance for the management of suspected anthrax in drug users, 2010 (http:\/\/www.documents.hps.scot.nhs.uk\/giz\/anthrax-outbreak\/clinical-guidance-for-use-of-anthrax-immune-globulin-v12-1-2010-03-19.pdf). Accessed 4 April 2014."},{"key":"S0950268814001885_ref27","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki367"},{"key":"S0950268814001885_ref16","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201102-0209CI"},{"key":"S0950268814001885_ref6","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2010.082586"},{"key":"S0950268814001885_ref31","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis017"},{"key":"S0950268814001885_ref11","doi-asserted-by":"publisher","DOI":"10.2807\/ese.15.02.19464-en"},{"key":"S0950268814001885_ref37","doi-asserted-by":"publisher","DOI":"10.1186\/cc12010"},{"key":"S0950268814001885_ref25","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-51-11-990"},{"key":"S0950268814001885_ref23","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268805003845"},{"key":"S0950268814001885_ref1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-51-11-1001"},{"key":"S0950268814001885_ref36","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(99)00259-7"},{"key":"S0950268814001885_ref4","first-page":"261","article-title":"NHS Lanarkshire alert on anthrax and heroin use","volume":"46","author":"Health","year":"2012","journal-title":"HPS Weekly Report"},{"key":"S0950268814001885_ref29","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00210-10"},{"key":"S0950268814001885_ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-012-2541-0"},{"key":"S0950268814001885_ref30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2006.01625.x"},{"key":"S0950268814001885_ref12","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215112003210"},{"key":"S0950268814001885_ref3","unstructured":"National Anthrax Outbreak Control Team. An outbreak of anthrax among drug users in Scotland, December 2009 to December 2010. Health Protection Scotland, 2011."},{"key":"S0950268814001885_ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2009.07.003"},{"key":"S0950268814001885_ref35","doi-asserted-by":"publisher","DOI":"10.1086\/346035"},{"key":"S0950268814001885_ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60573-9"},{"key":"S0950268814001885_ref19","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2807\/ese.17.26.20204-en","article-title":"Fatal anthrax infection in a heroin user from southern Germany, June 2012","volume":"17","author":"Holzmann","year":"2012","journal-title":"Eurosurveillance"},{"key":"S0950268814001885_ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-012-2772-0"},{"key":"S0950268814001885_ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjps.2010.06.003"},{"key":"S0950268814001885_ref20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.323.7320.1017"},{"key":"S0950268814001885_ref22","unstructured":"Health Protection Scotland. Clinical algorithm, clinical evaluation and management of drug users with possible anthrax, 2010 (http:\/\/www.documents.hps.scot.nhs.uk\/giz\/anthrax-outbreak\/clinical-algorithm-part-of-clinical-guidance-v12-17032010-asv.pdf). Accessed 21 April 2014."},{"key":"S0950268814001885_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03133-0"},{"key":"S0950268814001885_ref32","doi-asserted-by":"publisher","DOI":"10.3390\/toxins3091185"},{"key":"S0950268814001885_ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.02.076"},{"key":"S0950268814001885_ref28","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn368"},{"key":"S0950268814001885_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jflm.2010.09.008"},{"key":"S0950268814001885_ref7","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-21"},{"key":"S0950268814001885_ref21","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-199702000-00014"},{"key":"S0950268814001885_ref38","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-9-107"},{"key":"S0950268814001885_ref24","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-51-11-971"},{"key":"S0950268814001885_ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2006.07.002"},{"key":"S0950268814001885_ref13","first-page":"843","article-title":"Injection anthrax\u00a0\u2013\u00a0a new outbreak in heroin users","volume":"109","author":"Grunow","year":"2012","journal-title":"Deutsches \u00c4rzteblatt International"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268814001885","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T07:53:07Z","timestamp":1649836387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268814001885\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,31]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0950268814001885"],"URL":"https:\/\/doi.org\/10.1017\/s0950268814001885","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,31]]},"assertion":[{"value":"Copyright \u00a9 Cambridge University Press 2014\u00a0","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}